2022
Longitudinal association between exposome score for schizophrenia and clinical features: results from the Athens First-Episode Psychosis Research Study
Erzin G, Pries L, Dimitrakopoulos S, Ralli I, Xenaki L, Soldatos R, Vlachos I, Selakovic M, Foteli S, Kosteletos I, Nianiakas N, Mantonakis L, Rizos E, Kollias K, Os J, Guloksuz S, Stefanis N. Longitudinal association between exposome score for schizophrenia and clinical features: results from the Athens First-Episode Psychosis Research Study. European Psychiatry 2022, 65: s760-s760. PMCID: PMC9567635, DOI: 10.1192/j.eurpsy.2022.1963.Peer-Reviewed Original ResearchPANSS total scoreFirst-episode psychosisClinical featuresES-SCZTotal scoreIllness coursePsychosis developmentLongitudinal associationsEnvironmental exposuresTime interactionNegative Syndrome ScaleExposome scoreEpisode psychosisSyndrome ScaleSymptom severitySchizophreniaEnvironmental predispositionMultilevel regression analysisScoresRegression analysisFollowPrevious reportsBaselineAssociationCurrent study
2019
O6.7. TESTING THE HIGH RISK AND TRANSITION FRAMEWORK IN THE GENERAL POPULATION: POPULATION-BASED MEASURES OF RISK AND TRANSITION FOR PSYCHOSIS 6-YEAR LONGITUDINAL FOLLOW-UP
Pries L, Guloksuz S, Have M, de Graaf R, van Dorsselaer S, Rutten B, Van Os J. O6.7. TESTING THE HIGH RISK AND TRANSITION FRAMEWORK IN THE GENERAL POPULATION: POPULATION-BASED MEASURES OF RISK AND TRANSITION FOR PSYCHOSIS 6-YEAR LONGITUDINAL FOLLOW-UP. Schizophrenia Bulletin 2019, 45: s178-s178. PMCID: PMC6455329, DOI: 10.1093/schbul/sbz021.223.Peer-Reviewed Original Research